{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:20:49Z","timestamp":1786990849654,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T00:00:00Z","timestamp":1540166400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS","doi-asserted-by":"publisher","award":["16K21233"],"award-info":[{"award-number":["16K21233"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ijpddr.2018.10.006","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T13:58:28Z","timestamp":1540303108000},"page":"451-458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Toll-Like Receptor 2 agonist PEG-Pam2Cys as an immunochemoprophylactic and immunochemotherapeutic against the liver and transmission stages of malaria parasites"],"prefix":"10.1016","volume":"8","author":[{"given":"Medard","family":"Ernest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Hunja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Arakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Haraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein M.","family":"Abkallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Culleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2018.10.006_bib1","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/ni.1792","article-title":"Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands","volume":"10","author":"Barbalat","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ijpddr.2018.10.006_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01024-15","article-title":"Inactivated influenza vaccine that provides rapid, innate-immune-system-mediated protection and subsequent long-term adaptive immunity","volume":"6","author":"Chua","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.ijpddr.2018.10.006_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/187152106774755590","article-title":"Mechanisms of drug resistance in malaria: current and new challenges","volume":"5","author":"Cravo","year":"2006","journal-title":"Anti-Infect. Agents Med. Chem."},{"key":"10.1016\/j.ijpddr.2018.10.006_bib4","doi-asserted-by":"crossref","first-page":"8461","DOI":"10.1073\/pnas.97.15.8461","article-title":"\u03b1 -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria","volume":"97","author":"Gonzalez-Aseguinolaza","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2018.10.006_bib5","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ijpara.2012.07.001","article-title":"The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development","volume":"42","author":"Inoue","year":"2012","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2018.10.006_bib6","doi-asserted-by":"crossref","first-page":"15440","DOI":"10.1073\/pnas.0406740101","article-title":"A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses","volume":"101","author":"Jackson","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2018.10.006_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/00365548.2013.822093","article-title":"Recurrent Plasmodium vivax malaria due to dose-dependent primaquine resistance: a case report","volume":"46","author":"Kristensen","year":"2014","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2018.10.006_bib8","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/intimm\/dxl114","article-title":"Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines","volume":"18","author":"Lau","year":"2006","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ijpddr.2018.10.006_bib9","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1128\/IAI.02796-14","article-title":"Innate immunity induced by Plasmodium liver infection inhibits malaria reinfections","volume":"83","author":"Liehl","year":"2015","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijpddr.2018.10.006_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nm.3424","article-title":"Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection","volume":"20","author":"Liehl","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijpddr.2018.10.006_bib11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bjh.12665","article-title":"G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications","volume":"164","author":"Luzzatto","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ijpddr.2018.10.006_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/icb.2015.81","article-title":"Mapping the pulmonary environment of animals protected from virulent H1N1 influenza infection using the TLR-2 agonist Pam(2)Cys","volume":"94","author":"Mifsud","year":"2016","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.ijpddr.2018.10.006_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/icb.2015.71","article-title":"Reducing the impact of influenza-associated secondary pneumococcal infections","volume":"94","author":"Mifsud","year":"2016","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.ijpddr.2018.10.006_bib14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.celrep.2014.03.018","article-title":"Interferon-mediated innate immune responses against malaria parasite liver stages","volume":"7","author":"Miller","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijpddr.2018.10.006_bib15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1084\/jem.173.3.523","article-title":"Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential","volume":"173","author":"Naotunne","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijpddr.2018.10.006_bib16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ijpddr.2018.10.006_bib17","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1021\/mp300257x","article-title":"Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in mice","volume":"9","author":"Tan","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpddr.2018.10.006_bib18","doi-asserted-by":"crossref","first-page":"18239","DOI":"10.1038\/srep18239","article-title":"The TLR2 is activated by sporozoites and suppresses intrahepatic rodent malaria parasite development","volume":"5","author":"Zheng","year":"2015","journal-title":"Sci. Rep."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320718300630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320718300630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:49:42Z","timestamp":1761922182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320718300630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2211320718300630"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2018.10.006","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Toll-Like Receptor 2 agonist PEG-Pam2Cys as an immunochemoprophylactic and immunochemotherapeutic against the liver and transmission stages of malaria parasites","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2018.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}